Goldman-Backed Biotech Attovia Seeks $212.5M in Nasdaq IPO
Goldman Sachs-backed biotech firm Attovia is seeking $212.5 million in a US IPO, signaling ongoing appetite for healthcare listings amid cautious equity…
Goldman Sachs-backed biotech firm Attovia is seeking $212.5 million in a US IPO, signaling ongoing appetite for healthcare listings amid cautious equity…
Angola's historic $321 million IPO energizes the local stock market and highlights expanding investment opportunities in Africa's frontier economies.
China's top memory chipmaker CXMT soared 472% on its first day of trading after a $9.8 billion IPO, reflecting strong appetite for…
Euronext mulls a private market to rival the UK's, aiming to diversify revenue and strengthen its competitive position in European capital markets.
Scribe Therapeutics, backed by Eli Lilly, raised $128.7 million in an upsized IPO, reflecting strong investor demand for biotech firms with major…
The largest Australian IPO since 2018 starts trading on the ASX, bolstering the benchmark index and attracting investor attention to the region's…
Bank of America taps Pauli as Asia Pacific capital markets chief, signaling a strategic push to expand its investment banking footprint in…
SK Hynix considers expanding its U.S. equity offerings to attract global investors, per Chairman Chey Tae-won, amid surging demand for AI-related memory…
A top Indian asset manager launched a $1.22 billion IPO with a set price range, highlighting strong capital market activity and potential…
Angola aims to raise $320 million via its largest-ever IPO, advancing efforts to diversify its oil-dependent economy and develop the Angolan stock…
Brookfield-backed data center Csquare aims for a $1.35 billion IPO, signaling strong investor appetite for digital infrastructure.
Genneia's US IPO filing, the first from Argentina in over seven years, highlights improving market access for Argentine companies and may lift…